2024年3月5日 · Bedford and Elliman warn that measles cases are increasing, putting at risk the health of children who are unvaccinated. 1 What can primary care teams do to boost measles, mumps, and rubella (MMR) vaccine uptake?

2011年1月6日 · In a series of articles starting this week, and seven years after first looking into the MMR scare, journalist Brian Deer now shows the extent of Wakefield’s fraud and how it was perpetrated (doi:10.1136/bmj.c5347). Drawing on interviews, documents, and data made public at the GMC hearings, Deer shows how Wakefield altered …

2022年3月30日 · The latest data for July to September 2021 reported 88.6% uptake of the first dose of MMR at 24 months, with 85.5% uptake of two doses at 5 years—a decline on previous quarters. 2 Even a small decline in MMR vaccine uptake—the “canary in the coalmine”—can herald disease outbreaks.

DOI: 10.1136/bmj.d5703 Abstract Problem: As measles is a highly infectious disease, the United Kingdom recommendation is for at least 95% of children to receive a first vaccination with the measles, mumps, and rubella (MMR) vaccine before age 2 years and a booster before age 5 years to achieve herd immunity and prevent outbreaks.

2024年3月5日 · Increasing measles, mumps, and rubella (MMR) vaccine uptake in primary care

2022年3月30日 · We need to increase MMR uptake urgently. We need to increase MMR uptake urgently. We need to increase MMR uptake urgently BMJ. 2022 Mar 30:376:o818. doi: 10.1136/bmj.o818. Authors Helen Bedford 1 , Helen Donovan 2 Affiliations 1 UCL Great Ormond Street Institute of Child Health. 2 Royal College of Nursing. PMID: 35354576 DOI ...

Coverage of second dose of MMR decreased from 85.0% (95% CI 84.7% to 85.3%) at its height on ISO week 37 (2020) to 84.1% (95% CI 83.8% to 84.4%) by the end of the study. The break point in trends for MMR was at ISO week 34 (2020) (95% CI weeks 32–37 (2020)), while for pneumococcal vaccine the break point was later at ISO week 3 (2021) (95% CI ...

MMR Vaccine: Is It Safer Than Measles, Mumps, and Rubella? Assess the risks of measles, mumps, and rubella compared to the risks of the MMR vaccine. ... PIC Letter in The BMJ. Insufficient evidence that mandatory measles vaccination results in a …

Data on uptake of the measles mumps and rubella (MMR) vaccine in the United Kingdom are available through the COVER/Korner programme.1 2 The programme measures uptake of the MMR vaccine for children resident in a district on the evaluation date who reached their second birthday during the previous quarter.

2023年6月7日 · Objective To test for potential non-specific effects of an additional, early measles, mumps, and rubella (MMR) vaccine at age 5-7 months on risk of infection related hospitalisation before age 12 months. Design Randomised, double blinded, placebo controlled trial. Setting Denmark, a high income setting with low exposure to MMR.